Roche begins agency search for cancer drug

Roche is set to launch an agency review for its oncology drug MabThera.

Roche begins agency search for cancer drug
Roche begins agency search for cancer drug

The company has approached several UK healthcare PR specialists with a request for information, ahead of putting together a shortlist to pitch for the brief for the non-Hodgkin's lymphoma treatment.

It is understood that Amy Brice, international comms leader for the oncology arm of Roche, is overseeing the pitch process. It is unclear whether incumbent Ketchum will repitch for the account.

MabThera sits within the Roche portfolio of oncology brands alongside cancer care medication such as Avastin, Herceptin, Xeloda and Tarceva.

The Roche Group is a provider of cancer care medication including anti-cancer treatments, supportive care products and diagnostics.

It also has a wide portfolio of tumour markers as well as a range of molecular oncology tests.

The MabThera drug is harvested from Chinese hamster ovary (CHO) cells in suspension and is supplied as sterile, clear, preservative-free liquid prepared for intravenous treatment.

MabThera competes in an increasingly crowded product category. Fellow pharma companies jostling for market share include Novartis, with its lymphoma drug Lucatumumab, and several new products about to be introduced into the sector, including a tobacco-based vaccine from Swiss pharmaceutical company Bayer, which is currently undergoing human trials.

Roche was not available for comment regarding the review.

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Max Clifford trial jury to reconvene tomorrow after majority verdicts direction

Max Clifford trial jury to reconvene tomorrow after majority verdicts direction

The jury in the trial of celebrity publicist Max Clifford on 11 charges of indecent assault has been sent home for the day after being told by the judge earlier this afternoon that he will now accept majority verdicts.

Labour "fooling themselves" over plans to combat attacks on Miliband

Labour "fooling themselves" over plans to combat attacks on Miliband

Conservative-leaning public affairs experts have questioned the value of Labour's adoption of US-style campaigning tactics in the wake of the opposition hiring election strategist David Axelrod.

PLMR appoints Professor Tim Morris as non-executive director

The vet who helped establish the British Horseracing Authority's anti-doping and animal welfare programme has joined PLMR as a non-executive director.